Researchers from the Philippines and China have collaborated on developing a rapid and precise diagnostic technology for early screening of autoimmune diseases, such as lupus and arthritis.
The project, jointly funded by the Department of Science and Technology (DOST) of the Philippines and China’s Ministry of Science and Technology (MOST), aims to create a minimally-invasive procedure that could revolutionize the diagnosis of these challenging conditions.
The Filipino research team, led by DOST Balik Scientist Dr. Jonel Saludes from the University of San Agustin in Iloilo, is working closely with experts from Tsinghua University in Beijing.
The project, named “SinoPhil CHARRME: China-Philippines Cooperation for Harnessing and Accelerating Research and Resources on Microvesicles and Exosomes,” utilizes peptide science and lipidomics to identify biomarkers in patients’ bodily fluids, potentially replacing the need for traditional, more invasive diagnostic procedures like biopsies.
“This project is a testament to how the DOST actively seeks out partnerships that will benefit our communities,” said DOST Secretary Renato U. Solidum Jr.
“It is our hope that through this initiative, we will be able to bring a diagnostic tool that is efficient and reliable for the mutual benefit of the citizens of the Philippines and China.”
The research is currently in its third and final year, with the team having successfully designed, fabricated, and tested a microfluidic chip intended for use as a diagnostic tool.
The innovation holds promise for providing a faster, more accurate diagnosis of autoimmune diseases, which are often difficult to detect early.
“Early screening of diseases is critically important for timely intervention. By supporting this project, we hope to contribute to the advancement of a minimally-invasive diagnostic technology that will cater to a broad spectrum of autoimmune diseases,” said DOST-PCHRD Executive Director Dr. Jaime Montoya.
The initiative underscores the importance of international collaboration in addressing global health challenges and the potential of science and technology in improving healthcare outcomes.
Funded by DOST and monitored by the Philippine Council for Health Research and Development, the project is expected to have a lasting impact on the diagnostic capabilities available for autoimmune diseases, benefiting both the Philippines and China. (DOST-PCHRD)
